Accsys H1 2025: 160% EBITDA surge to €10.4m, driven by booming Accoya sales and JV momentum.
This article covers information on Accsys Technologies PLC.
LON:AXSAccsys Technologies has delivered a punchy first half for the six months to 30 September 2025. The headline is profitability: adjusted EBITDA rose 160% to €10.4 million, lifting the margin to 11.6% and nudging close to management’s Phase 1 FOCUS target of 12%. Total Accoya sales volumes including the US joint venture climbed 22.4% to 38,618 m³, with North America the standout.
There is still a small statutory loss, but the direction of travel is clearly improving. Below I break down what moved the numbers, why it matters, and what to watch next.
| Metric | H1 FY26 | H1 FY25 | Change |
|---|---|---|---|
| Group revenue | €76.1m | €72.2m | +5.4% |
| Aggregated revenue (Group + 60% of JV) | €89.9m | €74.1m | +21.3% |
| Gross profit | €23.2m | €22.2m | +4.5% |
| Gross margin | 30.5% | 30.7% | -20 bps |
| Adjusted EBITDA | €10.4m | €4.0m | +160% |
| Adjusted EBITDA margin | 11.6% | 5.4% | +620 bps |
| Period end net debt | (€39.8m) | (€40.2m) | €0.4m better |
| Group sales volumes | 30,575 m³ | 30,372 m³ | +0.7% |
| JV sales volumes | 8,043 m³ | 1,181 m³ | n/m |
| Total Accoya volumes | 38,618 m³ | 31,553 m³ | +22.4% |
Definitions: adjusted EBITDA is operating profit before exceptional items, depreciation and amortisation, and includes Accsys’ 60% share of the JV’s EBITDA. The aggregated revenue metric is Group revenue plus 60% of JV revenue.
One caveat is gross margin, which slipped 20 bps to 30.5%, mainly because North American sales moved from the Group into the JV in the comparable period and US sales typically carry higher average prices.
North America is the growth engine. Sales volumes here were up 61.4% to 8,043 m³, driven by stronger distributor sell-through and better product availability. Three new distributors were added, including the first direct distributor in Mexico, which should contribute in H2.
The JV is close to EBITDA break-even for the half, posting only a €0.3 million loss as operations ramp. Management expects the JV to be EBITDA positive for the full year, notwithstanding the 10% US tariff on imported lumber effective 14 October 2025. The company says actions have been taken to manage that impact and it is monitoring developments.
For context, Group revenue growth understates the true commercial momentum because prior period North American sales are now booked in the JV. On a like-for-like basis excluding those prior NA sales, Group revenue grew 23%.
Operations are running well. At Barry, capacity for Accoya Color has been more than doubled with an extra shift and added storage. Arnhem built inventory ahead of the October maintenance stop to support Q3.
Operating cash flow was €8.0 million with a 75% conversion rate, in line with the FOCUS Phase 1 target. Inventory increased to support growth and the maintenance stop, so free cash flow came in at €5.1 million, lower year on year.
Net debt reduced to €39.8 million at 30 September 2025, down from €42.6 million at 31 March 2025. The leverage ratio improved to 2.1x from 2.5x. After period end, Accsys refinanced with new €55 million facilities shared between ABN AMRO and HSBC, comprising a €20 million term loan and a €35 million revolving credit facility, maturing in October 2028 with an option to extend to 2029. Management describes the terms as improved and liquidity as strengthened.
The P&L is still loss making at the bottom line, albeit much improved: an underlying and statutory loss before tax of €1.4 million versus a €26.2 million statutory loss last year that included large exceptional charges. There was a non-cash €1.134 million fair value loss on the embedded derivative in the convertible loan notes, and a small tax credit from a €0.7 million refund, resulting in a basic loss per share of €0.01.
Trading is described as robust, with Accsys growing market share across regions. Sales are accelerating in North America and the Board expects full-year adjusted EBITDA to be in line with its expectations, with further progress towards strategic targets. The JV is expected to be EBITDA positive for the year.
In my view, this is a high-quality set of interim results. The group is executing the FOCUS plan, proving its pricing power and scaling the US asset. There is more to do to convert strong operating progress into bottom-line profits and cash, but the direction is clear. For investors, the key catalysts into H2 are continued NA volume momentum, confirmation of JV EBITDA positivity, and disciplined working capital as growth continues.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
33 viewsLikes
No ratings yet
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.